Arrayjet is a niche biotechnology company, providing innovative microarray and bio-printing solutions to diagnostic companies, drug development groups and life-science researchers worldwide. It is a quality company, with ISO 13485:2016 accreditation.
Arrayjet’s platform technology is built around unique non-contact, inkjet technology which consistently delivers pico-litre to nano-litre volumes, for high quality microarray and biochip production. It manufactures and sells instruments direct to customers for in-house use, as well as offering Arrayjet Advance, which provides outsourced contract research and screening.
MBO by Arrayjet management team in 2026. Transaction value not disclosed.
